関連する実験動画
Updated: Jan 6, 2026
01:19
Mitral Valve Prolapse III: Nursing Management
Published on: June 19, 2025
252
ニューロンの初期の遺伝子発現は,永続的な表遺伝子状態を調節する
Hume Stroud1, Susan C Su1, Sinisa Hrvatin1
1Department of Neurobiology, Harvard Medical School, Boston, MA 02115, USA.
Cell
|October 24, 2017
まとめ
DNAメチル化パターンを影響して 脳の発達を形作ります DNMT3A酵素は,神経細胞の遺伝子発現に影響する,転写と環境要因によって調節される低発現遺伝子にDNAメチル化 (mCA) を蓄積する.
科学分野:
- 神経科学
- エピジェネティクス
- 分子生物学
背景:
- 哺乳類のニューロン発育には環境要因が不可欠です
- これらの発達変化の根底にあるエピジェネティックメカニズムは完全に理解されていません.
研究 の 目的:
- 早期の脳の発達における表遺伝的調節の分子メカニズムを解明する
- ニューロンの遺伝子発現におけるDNAメチルトランスファーゼDNMT3Aの役割を調査する.
主な方法:
- 脳のDNAメチルトランスファーゼDNMT3A結合パターンの分析
- 遺伝子体内のCA配列 (mCA) でのDNAメチル化の評価
- 遺伝子転写,DNMT3Aの占有率,およびmCAの堆積の関係に関する調査.
- 生後期の経験がこれらの表遺伝的変化に与える影響を調べる.
主要な成果:
- DNMT3Aは,幼児の脳の低発現遺伝子の転写領域に一時的に結合する.
- DNMT3A結合は,これらの遺伝子内のmCAパターンを指定します.
- 遺伝子転写はDNMT3Aの占有率とmCAの堆積を否定的に制御する.
- 初期の経験はDNMT3Aの結合とmCAの堆積を変化させる可能性があります.
- メチルDNA結合タンパク質MECP2は,蓄積されたmCAに結合する.
- mCAは,脳機能に不可欠な細胞型特異的な遺伝子転写を微調整するレオスタットとして作用します.
結論:
- DNMT3A媒介によるmCAの蓄積は,幼児期の脳の発達における重要な表遺伝的メカニズムである.
- 脳の発達に対する環境の影響は,mCAのような表遺伝的変化によって媒介されます.
- 重要なニューロンの遺伝子をmCAによって微調整することは 適切な脳機能に不可欠です
関連する概念動画
Mitral Valve Prolapse III: Nursing Management
252
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
252
Cancer Vaccines
917
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
917
Development of Immunocompetence
759
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
759
Vaccinations
51.1K
Overview
51.1K
Healthcare Associated Infections II: Preventive Measures
3.5K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.5K
Teratogenicity
3.9K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.9K